BRL Medicine has built a core management team that combines exceptional leadership with strong execution capabilities. The team members possess deep research expertise in cell and gene therapy as well as extensive experience in industrial translation. The company’s founder, Dr.Mingyao Liu, currently serves as Chairman. He is a recipient of multiple prestigious awards, including the First Prize of the National Science and Technology Progress Award and the First Prize of the Shanghai Science and Technology Progress Award, and has long been dedicated to the development and application of cutting-edge technologies such as gene editing and cell therapy. Under his leadership, the company has continuously attracted distinguished scientists and entrepreneurs with outstanding achievements in drug discovery, clinical translation, and industrial operations, forming a high-caliber talent team that is interdisciplinary and integrates academia, research, and industry. This talent pool provides solid technical support and strategic assurance for the efficient advancement of the company’s pipeline and the systematic development of its technology platforms.